CREB1 and metastatic melanoma: On the other hand, MCAM/MUC18, which has been shown to be upregulated in metastatic melanoma cell lines [43], [44], [45], was found to be significantly downregulated by 90% in both cell lines after CREB silencing (Figure 5C).